HAVCR2 and breast cancer: At the same time, breast cancer cells highly express a variety of immunosuppressive molecules, such as Programmed Death Ligand 1 (PD-L1) and T-cell immunoglobulin and Mucin Domain 3 (TIM-3), which inhibit the activity of T cells (59–61).